Yueming seaweed group is a listed company. Qingdao Yueming Seaweed Group recently completed the registration of ultra-pure sodium alginate for in vivo implantation in CDE (Drug Evaluation Center of State Pharmaceutical Product Supervision Administration), which indicates that in vivo implanted sodium alginate has broken foreign monopoly and officially listed. Yueming seaweed group co., ltd was established in 1968. It is a large-scale marine health industry group engaged in the deep development and high-value application of seaweed active substances. The company mainly engaged in mechanical equipment, including machine tool operation station, equipment maintenance station, installation and assembly workers, etc.